Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Nasal Tramazoline and Dexamethazone in Obstructive Sleep Apnea (OSA) Patients Tramazoline and (NTD)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Ioannis Koutsourelakis, University of Athens
ClinicalTrials.gov Identifier:
NCT01601509
First received: March 4, 2012
Last updated: May 17, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2012
  Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):